{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:43:18Z","timestamp":1779108198479,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002387","name":"National Cancer Institute, Cairo University","doi-asserted-by":"publisher","award":["T32 CA067754"],"award-info":[{"award-number":["T32 CA067754"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["PF-18-101-01-CSM"],"award-info":[{"award-number":["PF-18-101-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA160911"],"award-info":[{"award-number":["R01CA160911"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA100768"],"award-info":[{"award-number":["R01CA100768"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A loss of balance between G protein activation and deactivation has been implicated in the initiation of melanomas, and non-canonical Wnt signaling via the Wnt5A\/Frizzled (FZD) pathway has been shown to be critical for the switch to an invasive phenotype. Daple [CCDC88C], a cytosolic guanine nucleotide exchange modulator (GEM) which enhances non-canonical Wnt5A\/FZD signaling via activation of trimeric G protein, G\u03b1i, has been shown to serve opposing roles\u2013as an inducer of EMT and invasiveness and a potent tumor suppressor\u2013via two isoforms, V1 (full-length) and V2\u00a0(short spliced isoform), respectively. Here we report that the relative abundance of these isoforms in the peripheral circulation,\u00a0presumably largely from circulating tumor cells (CTCs), is a prognostic marker of cutaneous melanomas. Expression of V1 is increased in both the early and late clinical stages (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002, respectively); V2 is decreased exclusively in the late clinical stage (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003). The two isoforms have opposing prognostic effects: high expression of V2 increases relapse-free survival (RFS;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.014), whereas high expression of V1 tends to decrease RFS (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.051). Furthermore, these effects are additive, in that melanoma patients with a low V2-high V1 signature carry the highest risk of metastatic disease. We conclude that detection of Daple transcripts in the peripheral blood (i.e., liquid biopsies) of patients with melanoma may serve as a prognostic marker and an effective strategy for non-invasive long-term follow-up of patients with melanoma.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-36173-x","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T12:49:09Z","timestamp":1545050949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Ying","family":"Dunkel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-7748","authenticated-orcid":false,"given":"Jason","family":"Ear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-9932","authenticated-orcid":false,"given":"Nicolas","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Millward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-3570","authenticated-orcid":false,"given":"Elin","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-3538","authenticated-orcid":false,"given":"Melanie","family":"Ziman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradipta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"36173_CR1","doi-asserted-by":"publisher","unstructured":"Faries, M. B., Steen, S., Ye, X., Sim, M. & Morton, D. L. Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg 217, 27\u201334 discussion 34\u201326, https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.03.007 (2013).","DOI":"10.1016\/j.jamcollsurg.2013.03.007"},{"key":"36173_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JAM Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso, J. A. M. mechanisms and clinical evidence for cancer dormancy. Nature reviews. Cancer 7, 834\u2013846, https:\/\/doi.org\/10.1038\/nrc2256 (2007).","journal-title":"Nature reviews. Cancer"},{"key":"36173_CR3","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1158\/1078-0432.CCR-06-0823","volume":"12","author":"S Mocellin","year":"2006","unstructured":"Mocellin, S., Hoon, D., Ambrosi, A., Nitti, D. & Rossi, C. R. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clinical cancer research: an official journal of the American Association for Cancer Research 12, 4605\u20134613, https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0823 (2006).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"36173_CR4","first-page":"146","volume":"14","author":"TR Ashworth","year":"1869","unstructured":"Ashworth, T. R. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australian Medical Journal 14, 146\u2013147 (1869).","journal-title":"Australian Medical Journal"},{"key":"36173_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/CMR.0000000000000168","volume":"25","author":"CL Roland","year":"2015","unstructured":"Roland, C. L. et al. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma research 25, 335\u2013341, https:\/\/doi.org\/10.1097\/CMR.0000000000000168 (2015).","journal-title":"Melanoma research"},{"key":"36173_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-192","volume":"10","author":"JB Freeman","year":"2012","unstructured":"Freeman, J. B., Gray, E. S., Millward, M., Pearce, R. & Ziman, M. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of translational medicine 10, 192, https:\/\/doi.org\/10.1186\/1479-5876-10-192 (2012).","journal-title":"Journal of translational medicine"},{"key":"36173_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/bjd.12057","volume":"168","author":"AL Reid","year":"2013","unstructured":"Reid, A. L. et al. Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. The British journal of dermatology 168, 85\u201392, https:\/\/doi.org\/10.1111\/bjd.12057 (2013).","journal-title":"The British journal of dermatology"},{"key":"36173_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1373\/clinchem.2004.045096","volume":"51","author":"K Koyanagi","year":"2005","unstructured":"Koyanagi, K. et al. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients. Clinical chemistry 51, 981\u2013988, https:\/\/doi.org\/10.1373\/clinchem.2004.045096 (2005).","journal-title":"Clinical chemistry"},{"key":"36173_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/annonc\/mdu207","volume":"26","author":"L Khoja","year":"2015","unstructured":"Khoja, L., Lorigan, P., Dive, C., Keilholz, U. & Fusi, A. Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance. Annals of oncology: official journal of the European Society for Medical Oncology 26, 33\u201339, https:\/\/doi.org\/10.1093\/annonc\/mdu207 (2015).","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"36173_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejca.2010.10.005","volume":"47","author":"MG Bouwhuis","year":"2011","unstructured":"Bouwhuis, M. G. et al. Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952. European journal of cancer 47, 361\u2013368, https:\/\/doi.org\/10.1016\/j.ejca.2010.10.005 (2011).","journal-title":"European journal of cancer"},{"key":"36173_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1155\/2006\/462065","volume":"22","author":"E Carrillo","year":"2006","unstructured":"Carrillo, E. et al. Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients. Disease markers 22, 175\u2013181 (2006).","journal-title":"Disease markers"},{"key":"36173_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08998280.2008.11928377","volume":"21","author":"S Steen","year":"2008","unstructured":"Steen, S., Nemunaitis, J., Fisher, T. & Kuhn, J. Circulating tumor cells in melanoma: a review of the literature and description of a novel technique. Proc (Bayl Univ Med Cent) 21, 127\u2013132 (2008).","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"36173_CR13","first-page":"2253","volume":"60","author":"DS Hoon","year":"2000","unstructured":"Hoon, D. S. et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer research 60, 2253\u20132257 (2000).","journal-title":"Cancer research"},{"key":"36173_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bjc.6600419","volume":"87","author":"H Gogas","year":"2002","unstructured":"Gogas, H. et al. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon. British journal of cancer 87, 181\u2013186, https:\/\/doi.org\/10.1038\/sj.bjc.6600419 (2002).","journal-title":"British journal of cancer"},{"key":"36173_CR15","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1038\/jid.2008.170","volume":"128","author":"KV Shah","year":"2008","unstructured":"Shah, K. V., Chien, A. J., Yee, C. & Moon, R. T. CTLA-4 is a direct target of Wnt\/beta-catenin signaling and is expressed in human melanoma tumors. The Journal of investigative dermatology 128, 2870\u20132879, https:\/\/doi.org\/10.1038\/jid.2008.170 (2008).","journal-title":"The Journal of investigative dermatology"},{"key":"36173_CR16","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI70156","volume":"124","author":"JN Anastas","year":"2014","unstructured":"Anastas, J. N. et al. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. The Journal of clinical investigation 124, 2877\u20132890, https:\/\/doi.org\/10.1172\/JCI70156 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"36173_CR17","doi-asserted-by":"publisher","first-page":"e0125028","DOI":"10.1371\/journal.pone.0125028","volume":"10","author":"JM Atkinson","year":"2015","unstructured":"Atkinson, J. M. et al. Activating the Wnt\/beta-Catenin Pathway for the Treatment of Melanoma\u2013Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3. PloS one 10, e0125028, https:\/\/doi.org\/10.1371\/journal.pone.0125028 (2015).","journal-title":"PloS one"},{"key":"36173_CR18","doi-asserted-by":"publisher","first-page":"e07091","DOI":"10.7554\/eLife.07091","volume":"4","author":"N Aznar","year":"2015","unstructured":"Aznar, N. et al. Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. Elife 4, e07091, https:\/\/doi.org\/10.7554\/eLife.07091 (2015).","journal-title":"Elife"},{"key":"36173_CR19","doi-asserted-by":"publisher","unstructured":"Aznar, N. et al. A Daple-Akt feed forward loop enhances non-canonical Wnt signals by compartmentalizing beta-Catenin. Molecular biology of the cell https:\/\/doi.org\/10.1091\/mbc.E17-06-0405 (2017).","DOI":"10.1091\/mbc.E17-06-0405"},{"key":"36173_CR20","doi-asserted-by":"publisher","unstructured":"Aznar, N. et al. Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple. Sci Signal 11, https:\/\/doi.org\/10.1126\/scisignal.aao4220 (2018).","DOI":"10.1126\/scisignal.aao4220"},{"key":"36173_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cas.12848","volume":"107","author":"H Ara","year":"2016","unstructured":"Ara, H. et al. Role for Daple in non-canonical Wnt signaling during gastric cancer invasion and metastasis. Cancer science 107, 133\u2013139, https:\/\/doi.org\/10.1111\/cas.12848 (2016).","journal-title":"Cancer science"},{"key":"36173_CR22","doi-asserted-by":"crossref","unstructured":"Dunkel, Y. et al. Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple Cooperate as Tumor Suppressors. In Revision, (BioRxiv, https:\/\/www.biorxiv.org\/content\/early\/2018\/05\/02\/312934) (2018).","DOI":"10.1101\/312934"},{"key":"36173_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep22112","volume":"6","author":"J Barbazan","year":"2016","unstructured":"Barbazan, J. et al. Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer. Sci Rep 6, 22112, https:\/\/doi.org\/10.1038\/srep22112 (2016).","journal-title":"Sci Rep"},{"key":"36173_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4161\/cbt.10.1.11949","volume":"10","author":"LI Cardenas-Navia","year":"2010","unstructured":"Cardenas-Navia, L. I. et al. Novel somatic mutations in heterotrimeric G proteins in melanoma. Cancer biology & therapy 10, 33\u201337 (2010).","journal-title":"Cancer biology & therapy"},{"key":"36173_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrc3521","volume":"13","author":"M O\u2019Hayre","year":"2013","unstructured":"O\u2019Hayre, M. et al. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nature reviews. Cancer 13, 412\u2013424, https:\/\/doi.org\/10.1038\/nrc3521 (2013).","journal-title":"Nature reviews. Cancer"},{"key":"36173_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599\u2013602, https:\/\/doi.org\/10.1038\/nature07586 (2009).","journal-title":"Nature"},{"key":"36173_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/15384101.2017.1282584","volume":"16","author":"P Ghosh","year":"2017","unstructured":"Ghosh, P., Rangamani, P. & Kufareva, I. The GAPs, GEFs, GDIs and\u2026now, GEMs: New kids on the heterotrimeric G protein signaling block. Cell Cycle 16, 607\u2013612, https:\/\/doi.org\/10.1080\/15384101.2017.1282584 (2017).","journal-title":"Cell Cycle"},{"key":"36173_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0140-6736(91)92100-G","volume":"338","author":"B Smith","year":"1991","unstructured":"Smith, B. et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338, 1227\u20131229 (1991).","journal-title":"Lancet"},{"key":"36173_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2013.10.036","volume":"344","author":"IJ Bettum","year":"2014","unstructured":"Bettum, I. J. et al. Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties. Cancer letters 344, 28\u201339, https:\/\/doi.org\/10.1016\/j.canlet.2013.10.036 (2014).","journal-title":"Cancer letters"},{"key":"36173_CR30","doi-asserted-by":"publisher","unstructured":"Dahlmann, M., Kobelt, D., Walther, W., Mudduluru, G. & Stein, U. S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction. Cancers 8, https:\/\/doi.org\/10.3390\/cancers8060059 (2016).","DOI":"10.3390\/cancers8060059"},{"key":"36173_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9","volume":"74","author":"GM Maelandsmo","year":"1997","unstructured":"Maelandsmo, G. M. et al. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. International journal of cancer 74, 464\u2013469 (1997).","journal-title":"International journal of cancer"},{"key":"36173_CR32","first-page":"1502","volume":"8","author":"X Luo","year":"2016","unstructured":"Luo, X. et al. Methylation-mediated loss of SFRP2 enhances melanoma cell invasion via Wnt signaling. Am J Transl Res 8, 1502\u20131509 (2016).","journal-title":"Am J Transl Res"},{"key":"36173_CR33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/archdermatol.2010.264","volume":"146","author":"V De Giorgi","year":"2010","unstructured":"De Giorgi, V. et al. Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. Archives of dermatology 146, 1120\u20131124, https:\/\/doi.org\/10.1001\/archdermatol.2010.264 (2010).","journal-title":"Archives of dermatology"},{"key":"36173_CR34","doi-asserted-by":"publisher","first-page":"e41052","DOI":"10.1371\/journal.pone.0041052","volume":"7","author":"GA Clawson","year":"2012","unstructured":"Clawson, G. A. et al. Circulating tumor cells in melanoma patients. PloS one 7, e41052, https:\/\/doi.org\/10.1371\/journal.pone.0041052 (2012).","journal-title":"PloS one"},{"key":"36173_CR35","first-page":"5975","volume":"9","author":"J Lee","year":"2010","unstructured":"Lee, J. et al. Conditions for the differentiation of melanocyte-precursor cells from human cord blood-derived mesenchymal stem cells. African J Biotechnology 9, 5975\u20135977 (2010).","journal-title":"African J Biotechnology"},{"key":"36173_CR36","doi-asserted-by":"publisher","first-page":"e16182","DOI":"10.1371\/journal.pone.0016182","volume":"6","author":"S Ohta","year":"2011","unstructured":"Ohta, S. et al. Generation of human melanocytes from induced pluripotent stem cells. PloS one 6, e16182, https:\/\/doi.org\/10.1371\/journal.pone.0016182 (2011).","journal-title":"PloS one"},{"key":"36173_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ab.2008.05.024","volume":"380","author":"O Giricz","year":"2008","unstructured":"Giricz, O., Lauer-Fields, J. L. & Fields, G. B. The normalization of gene expression data in melanoma: investigating the use of glyceraldehyde 3-phosphate dehydrogenase and 18S ribosomal RNA as internal reference genes for quantitative real-time PCR. Anal Biochem 380, 137\u2013139, https:\/\/doi.org\/10.1016\/j.ab.2008.05.024 (2008).","journal-title":"Anal Biochem"},{"key":"36173_CR38","doi-asserted-by":"publisher","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies, J. et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PloS one 7, e51862, https:\/\/doi.org\/10.1371\/journal.pone.0051862 (2012).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36173-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36173-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:16:19Z","timestamp":1671606979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36173-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["36173"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36173-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/346551","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18036"}}